Interestingly, blocking mTOR signaling completely prevents ketamine from inducing synaptogenesis and its antidepressant-like behaviors in depression models, highlighting the pivotal role of mTOR’s in ketamine’s rapid antidepressant effects. The gene discussed is MTOR; the disease is depressive symptom measurement.